Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models

BACKGROUND: Recent studies suggested that induction of epithelial-mesenchymal transition (EMT) might confer both metastatic and self-renewal properties to breast tumor cells resulting in drug resistance and tumor recurrence. TGFβ is a potent inducer of EMT and has been shown to promote tumor progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandyopadhyay, Abhik, Wang, Long, Agyin, Joseph, Tang, Yuping, Lin, Shu, Yeh, I-Tien, De, Keya, Sun, Lu-Zhe
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860989/
https://www.ncbi.nlm.nih.gov/pubmed/20442777
http://dx.doi.org/10.1371/journal.pone.0010365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860989/
https://www.ncbi.nlm.nih.gov/pubmed/20442777
http://dx.doi.org/10.1371/journal.pone.0010365

Ejemplares similares